Peer Review reports
From: Comprehensive analysis of the role of ICOS ( CD278 ) in pan-cancer prognosis and immunotherapy
Original Submission | ||
---|---|---|
14 Nov 2022 | Submitted | Original manuscript |
26 Nov 2022 | Reviewed | Reviewer Report |
28 Nov 2022 | Reviewed | Reviewer Report - Zeyuan Wang |
11 Dec 2022 | Author responded | Author comments - Hui Cai |
Resubmission - Version 2 | ||
11 Dec 2022 | Submitted | Manuscript version 2 |
21 Dec 2022 | Author responded | Author comments - Hui Cai |
Resubmission - Version 3 | ||
21 Dec 2022 | Submitted | Manuscript version 3 |
3 Jan 2023 | Author responded | Author comments - Hui Cai |
Resubmission - Version 4 | ||
3 Jan 2023 | Submitted | Manuscript version 4 |
11 Jan 2023 | Reviewed | Reviewer Report - Zeyuan Wang |
14 Jan 2023 | Reviewed | Reviewer Report |
Resubmission - Version 5 | ||
Submitted | Manuscript version 5 | |
Publishing | ||
19 Jan 2023 | Editorially accepted | |
28 Feb 2023 | Article published | 10.1186/s12885-023-10564-4 |
You can find further information about peer review here.